{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:11:31Z","timestamp":1782731491219,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1311733"],"award-info":[{"award-number":["1311733"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Optim Theory Appl"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10957-018-1218-4","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T20:21:45Z","timestamp":1516306905000},"page":"456-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Optimal Control for a Mathematical Model of Glioma Treatment with Oncolytic Therapy and TNF-$$\\alpha $$ Inhibitors"],"prefix":"10.1007","volume":"176","author":[{"given":"Elzbieta","family":"Ratajczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-1958","authenticated-orcid":false,"given":"Urszula","family":"Ledzewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Sch\u00e4ttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/B:NEON.0000021735.85511.05","volume":"67","author":"LK Csatary","year":"2004","unstructured":"Csatary, L.K., Gosztonyi, G., Szeberenyi, J., Fabian, Z., Liszka, V., Bodey, B., Csatary, C.M.: MTH-68\/H oncolytic viral treatment in human highgrade gliomas. J. Neurooncol. 67, 83\u201393 (2004)","journal-title":"J. Neurooncol."},{"key":"1218_CR2","first-page":"618","volume":"5","author":"RM Lorence","year":"2003","unstructured":"Lorence, R.M., Pecora, A.L., Major, P.P., Hotte, S.J., Laurie, S.A., Roberts, M.S., Groene, W.S., Bamat, M.K.: Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Curr. Opin. Mol. Ther. 5, 618\u2013624 (2003)","journal-title":"Curr. Opin. Mol. Ther."},{"key":"1218_CR3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301205","volume":"7","author":"JM Markert","year":"2000","unstructured":"Markert, J.M.: Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 7, 867\u2013874 (2000)","journal-title":"Gene Ther."},{"key":"1218_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nrc948","volume":"2","author":"EA Chiocca","year":"2002","unstructured":"Chiocca, E.A.: Oncolytic viruses. Nat. Rev. Cancer 2, 938\u201350 (2002)","journal-title":"Nat. Rev. Cancer"},{"issue":"34","key":"1218_CR5","doi-asserted-by":"publisher","first-page":"12873","DOI":"10.1073\/pnas.0605496103","volume":"103","author":"G Fulci","year":"2006","unstructured":"Fulci, G., Breymann, L., Gianni, D., Kurozomi, K., Rhee, S.S., Yu, J., Kaur, B., Louis, D.N., Weissleder, R., Caligiuri, M.A., Chiocca, E.A.: Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc. Natl. Acad. Sci. PNAS 103(34), 12873\u201312878 (2006)","journal-title":"Proc. Natl. Acad. Sci. PNAS"},{"issue":"4","key":"1218_CR6","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-05-2661","volume":"66","author":"A Friedman","year":"2006","unstructured":"Friedman, A., Tian, J., Fulci, G., Chioca, E., Wang, J.: Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res. 66(4), 2314\u20132319 (2006)","journal-title":"Cancer Res."},{"key":"1218_CR7","doi-asserted-by":"publisher","unstructured":"Auffinger, B., Ahmed, A.U., Lesniak, M.S.: Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice. Front. Oncol. (2013). https:\/\/doi.org\/10.3389\/fonc.2013.00032","DOI":"10.3389\/fonc.2013.00032"},{"issue":"1","key":"1218_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3934\/mbe.2017020","volume":"14","author":"E Ratajczyk","year":"2017","unstructured":"Ratajczyk, E., Ledzewicz, U., Leszczy\u0144ski, M., Friedman, A.: The role of TNF-alpha inhibitor in Glioma virotherapy: a mathematical model. Math. Biosci. Eng. 14(1), 305\u2013319 (2017)","journal-title":"Math. Biosci. Eng."},{"key":"1218_CR9","doi-asserted-by":"crossref","unstructured":"Ratajczyk, E., Ledzewicz, U., Leszczy\u0144ski, M., Sch\u00e4ttler, H.: Treatment of Glioma with virotherapy and TNF-$$\\alpha $$ inhibitors: analysis as a dynamical system. Discrete Contin. Dyn. Syst. Ser. B, 23(1), to appear (2018)","DOI":"10.3934\/dcdsb.2018029"},{"issue":"1","key":"1218_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jtbi.2008.01.016","volume":"252","author":"Z Bajzer","year":"2008","unstructured":"Bajzer, Z., Carr, T., Josi\u0107, K., Russell, S.J., Dingli, D.: Modeling of cancer virotherapy with recombinant viruses. J. Theor. Biol. 252(1), 109\u2013122 (2008)","journal-title":"J. Theor. Biol."},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/17513758.2011.613486","volume":"6","author":"JJ Crivelli","year":"2012","unstructured":"Crivelli, J.J., F\u00f6ldes, J., Kim, P.S., Wares, J.: A mathematical model for cell-cycle specific cancer virotherapy. J. Biol. Dyn. 6, 104\u2013120 (2012)","journal-title":"J. Biol. Dyn."},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.12785\/amis\/080256","volume":"8","author":"A El-alami Laaroussi","year":"2014","unstructured":"El-alami Laaroussi, A., El Hia, M.E., Rachik, M., Benlahmar, E., Rachik, Z.: Analysis of a mathematical model for treatment of cancer with oncolytic virotherapy. Appl. Math. Sci 8, 929\u2013940 (2014)","journal-title":"Appl. Math. Sci"},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1137\/08073740X","volume":"70","author":"Y Kogan","year":"2010","unstructured":"Kogan, Y., Forys, U., Shukron, O., Kronik, N., Agur, Z.: Cellular immunotherapy for high grade gliomas: mathematical analysis deriving efficacious infusion rates based on patient requirements. SIAM J. App. Math. 70, 1953\u20131976 (2010)","journal-title":"SIAM J. App. Math."},{"issue":"6","key":"1218_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3934\/mbe.2015.12.1237","volume":"12","author":"JR Wares","year":"2015","unstructured":"Wares, J.R., Crivelli, J.J., Yun, C., Choi, I., Gevertz, J.L., Kim, P.S.: Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections. Math. Biosci. Eng. 12(6), 1237\u20131256 (2015)","journal-title":"Math. Biosci. Eng."},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1142\/S0218339006001702","volume":"14","author":"U Forys","year":"2006","unstructured":"Forys, U., Waniewski, J., Zhivkov, P.: Anti-tumor immunity and tumor anti-immunity in a mathematical model of tumor immunotherapy. J. Biol. Syst. 14, 13\u201330 (2006)","journal-title":"J. Biol. Syst."},{"key":"1218_CR16","first-page":"202","volume":"208","author":"A dOnofrio","year":"2005","unstructured":"dOnofrio, A.: A general framework for modelling tumor-immune system competition and immunotherapy. Phys. D 208, 202\u2013235 (2005)","journal-title":"Phys. D"},{"key":"1218_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-93126-0","volume-title":"Mathematical Models in Cell Biology and Cancer Chemotherapy Lecture Notes in Biomathematics","author":"M Eisen","year":"1979","unstructured":"Eisen, M.: Mathematical Models in Cell Biology and Cancer Chemotherapy Lecture Notes in Biomathematics, vol. 30. Springer, Berlin (1979)"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/imammb\/5.4.303","volume":"5","author":"GW Swan","year":"1988","unstructured":"Swan, G.W.: General applications of optimal control theory in cancer chemotherapy, IMA. J. Math. Appl. Med. Biol. 5, 303\u2013316 (1988)","journal-title":"J. Math. Appl. Med. Biol."},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0025-5564(90)90021-P","volume":"101","author":"GW Swan","year":"1990","unstructured":"Swan, G.W.: Role of optimal control in cancer chemotherapy. Math. Biosci. 101, 237\u2013284 (1990)","journal-title":"Math. Biosci."},{"key":"1218_CR20","unstructured":"Swierniak, A.: Optimal treatment protocols in leukemia - modelling the proliferation cycle. In: Proceedings of 12th IMACS World Congress, Paris, 4, pp. 170\u2013172 (1988)"},{"key":"1218_CR21","first-page":"357","volume":"13","author":"A Swierniak","year":"2003","unstructured":"Swierniak, A., Ledzewicz, U., Sch\u00e4ttler, H.: Optimal control for a class of compartmental models in cancer chemotherapy. Int. J. Appl. Math. Comp. Sci. 13, 357\u2013368 (2003)","journal-title":"Int. J. Appl. Math. Comp. Sci."},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1142\/S0218339002000597","volume":"10","author":"U Ledzewicz","year":"2002","unstructured":"Ledzewicz, U., Sch\u00e4ttler, H.: Analysis of a cell-cycle specific model for cancer chemotherapy. J. Biol. Syst. 10, 183\u2013206 (2002)","journal-title":"J. Biol. Syst."},{"key":"1218_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1023\/A:1016027113579","volume":"114","author":"U Ledzewicz","year":"2002","unstructured":"Ledzewicz, U., Sch\u00e4ttler, H.: Optimal bang-bang controls for a 2-compartment model in cancer chemotherapy. J. Optim. Theory Appl. 114, 609\u2013637 (2002)","journal-title":"J. Optim. Theory Appl."},{"issue":"3","key":"1218_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1137\/060665294","volume":"46","author":"U Ledzewicz","year":"2007","unstructured":"Ledzewicz, U., Sch\u00e4ttler, H.: Antiangiogenic therapy in cancer treatment as an optimal control problem. SIAM J. Control Optim. 46(3), 1052\u20131079 (2007)","journal-title":"SIAM J. Control Optim."},{"key":"1218_CR25","doi-asserted-by":"crossref","unstructured":"Ledzewicz, U., Sch\u00e4ttler, H.: A synthesis of optimal controls for a model of tumor growth under angiogenic inhibitors. In: Proceedings of 44th IEEE Conference on Decision and Control, Sevilla, Spain, pp. 934\u2013939 (2005)","DOI":"10.1109\/CDC.2005.1582277"},{"key":"1218_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mbs.2009.08.004","volume":"222","author":"A dOnofrio","year":"2009","unstructured":"dOnofrio, A., Ledzewicz, U., Maurer, H., Sch\u00e4ttler, H.: On optimal delivery of combination therapy for tumors. Math. Biosci. 222, 13\u201326 (2009)","journal-title":"Math. Biosci."},{"key":"1218_CR27","doi-asserted-by":"publisher","first-page":"195224","DOI":"10.1007\/s10957-011-9954-8","volume":"153","author":"U Ledzewicz","year":"2012","unstructured":"Ledzewicz, U., Sch\u00e4ttler, H.: Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments. J. Optim. Theory Appl. 153, 195224 (2012)","journal-title":"J. Optim. Theory Appl."},{"key":"1218_CR28","doi-asserted-by":"crossref","unstructured":"dOnofrio, A., Ledzewicz, U., Sch\u00e4ttler, H.: On the dynamics of tumor immune system interactions and combined chemo- and immunotherapy. In: dOnofrio, A., Cerrai, P., Gandolfi, A. (eds.) New Challenges for Cancer Systems Biomedicine, SIMAI Springer series, Vol. 1, pp. 249\u2013266 (2012)","DOI":"10.1007\/978-88-470-2571-4_13"},{"key":"1218_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/10273660108833067","volume":"3","author":"LG de Pillis","year":"2001","unstructured":"de Pillis, L.G., Radunskaya, A.: A mathematical tumor model with immune resistance and drug therapy: an optimal control approach. J. Theor. Med. 3, 79\u2013100 (2001)","journal-title":"J. Theor. Med."},{"key":"1218_CR30","volume-title":"The Mathematical Theory of Optimal Processes","author":"LS Pontryagin","year":"1964","unstructured":"Pontryagin, L.S., Boltyanskii, V.G., Gamkrelidze, R.V., Mishchenko, E.F.: The Mathematical Theory of Optimal Processes. Macmillan, New York (1964)"},{"key":"1218_CR31","volume-title":"Singular Trajectories and their Role in Control Theory, Math\u00e9matiques & Applications","author":"B Bonnard","year":"2003","unstructured":"Bonnard, B., Chyba, M.: Singular Trajectories and their Role in Control Theory, Math\u00e9matiques & Applications, vol. 40. Springer, Paris (2003)"},{"key":"1218_CR32","volume-title":"Introduction to the Mathematical Theory of Control","author":"A Bressan","year":"2007","unstructured":"Bressan, A., Piccoli, B.: Introduction to the Mathematical Theory of Control. American Institute of Mathematical Sciences, San Jose (2007)"},{"key":"1218_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-3834-2","volume-title":"Geometric Optimal Control","author":"H Sch\u00e4ttler","year":"2012","unstructured":"Sch\u00e4ttler, H., Ledzewicz, U.: Geometric Optimal Control. Springer, New York (2012)"},{"key":"1218_CR34","volume-title":"Applied Optimal Control","author":"AE Bryson","year":"1975","unstructured":"Bryson, A.E., Ho, Y.C.: Applied Optimal Control. Hemisphere Publ. Co., Washington (1975)"},{"key":"1218_CR35","unstructured":"Ratajczyk, E.: Dynamics and Optimal Control of a Mathematical Model for Combination Therapy of Glioma. Ph.D. thesis at Lodz University of Technology, Lodz, Poland (2017)"},{"key":"1218_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-7904-5","volume-title":"Stable Mappings and their Singularities","author":"M Golubitsky","year":"1973","unstructured":"Golubitsky, M., Guillemin, V.: Stable Mappings and their Singularities. Springer, New York (1973)"},{"key":"1218_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2972-6","volume-title":"Optimal Control for Mathematical Models of Cancer Therapies","author":"H Sch\u00e4ttler","year":"2015","unstructured":"Sch\u00e4ttler, H., Ledzewicz, U.: Optimal Control for Mathematical Models of Cancer Therapies. Springer, New York (2015)"},{"issue":"3","key":"1218_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.7494\/OpMath.2017.37.3.403","volume":"37","author":"M Leszczy\u0144ski","year":"2017","unstructured":"Leszczy\u0144ski, M., Ratajczyk, E., Ledzewicz, U., Sch\u00e4ttler, H.: Sufficient conditions for optimality for a mathematical model of drug treatment with pharmacodynamics. Opuscula Math. 37(3), 403\u2013419 (2017)","journal-title":"Opuscula Math."}],"container-title":["Journal of Optimization Theory and Applications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10957-018-1218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10957-018-1218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10957-018-1218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T22:38:39Z","timestamp":1751236719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10957-018-1218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s10957-018-1218-4","relation":{},"ISSN":["0022-3239","1573-2878"],"issn-type":[{"value":"0022-3239","type":"print"},{"value":"1573-2878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"20 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}